• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
De novo malignancies in renal transplant recipients: experience at a single center in China.肾移植受者的新发恶性肿瘤:中国某单一中心的经验
Int J Clin Exp Med. 2015 Feb 15;8(2):2911-6. eCollection 2015.
2
De novo malignancies in renal transplant recipients: experience at a single center with 1882 transplant patients over 39 yr.肾移植受者的新发恶性肿瘤:39 年中在单一中心对 1882 例移植患者的经验
Clin Transplant. 2013 Jan-Feb;27(1):E30-6. doi: 10.1111/ctr.12050. Epub 2012 Dec 27.
3
Malignancy following renal transplantation.肾移植后的恶性肿瘤
Zhonghua Yi Xue Za Zhi (Taipei). 1998 May;61(5):281-8.
4
De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases.肾移植和肝移植后的新发恶性肿瘤:582例连续病例的经验
Transplant Proc. 2006 May;38(4):1135-7. doi: 10.1016/j.transproceed.2006.02.016.
5
malignancies after liver transplantation: The effect of immunosuppression-personal data and review of literature.肝移植后的恶性肿瘤:免疫抑制的影响——个人数据和文献回顾。
World J Gastroenterol. 2019 Sep 21;25(35):5356-5375. doi: 10.3748/wjg.v25.i35.5356.
6
Impact of cyclosporine versus tacrolimus on the incidence of de novo malignancy following liver transplantation: a single center experience with 609 patients.环孢素与他克莫司对肝移植后新发恶性肿瘤发生率的影响:单中心 609 例患者经验。
Transpl Int. 2013 Oct;26(10):999-1006. doi: 10.1111/tri.12165. Epub 2013 Aug 17.
7
Comparative Review of Standardized Incidence Ratio of Nonlymphoid, De Novo Malignancies After Liver Transplant Versus After Kidney Transplant.非淋巴造血系统、肝肾移植后新发恶性肿瘤标准化发病比的对比研究。
Exp Clin Transplant. 2024 Aug;22(8):600-606. doi: 10.6002/ect.2024.0136.
8
De-novo malignancies after kidney transplantation: A long-term observational study.肾移植后新发恶性肿瘤:一项长期观察性研究。
PLoS One. 2020 Nov 30;15(11):e0242805. doi: 10.1371/journal.pone.0242805. eCollection 2020.
9
De Novo Cancer Incidence and Prognosis After Kidney Transplantation: A Single Center Analysis.肾移植后新发癌症的发病率及预后:一项单中心分析
Transplant Proc. 2019 Nov;51(9):2927-2930. doi: 10.1016/j.transproceed.2019.04.096. Epub 2019 Oct 10.
10
De novo renal cell carcinoma of native kidney in renal transplant recipients.肾移植受者原发性肾的新发肾细胞癌
Cancer. 2005 Jan 15;103(2):251-7. doi: 10.1002/cncr.20745.

引用本文的文献

1
Current Status of Malignant Tumors after Organ Transplantation.器官移植后恶性肿瘤的现状。
Biomed Res Int. 2022 Feb 18;2022:5852451. doi: 10.1155/2022/5852451. eCollection 2022.

本文引用的文献

1
Spectrum of cancer risk among US solid organ transplant recipients.美国实体器官移植受者的癌症风险谱。
JAMA. 2011 Nov 2;306(17):1891-901. doi: 10.1001/jama.2011.1592.
2
Malignancies in 2,753 kidney recipients transplanted during a 39-year experience.在39年的经验中,2753名肾移植受者发生的恶性肿瘤。
Transplant Proc. 2009 May;41(4):1231-2. doi: 10.1016/j.transproceed.2009.03.032.
3
Minimizing the risk of posttransplant malignancy.将移植后恶性肿瘤的风险降至最低。
Transplantation. 2009 Apr 27;87(8 Suppl):S19-22. doi: 10.1097/TP.0b013e3181a07a57.
4
Cancers after renal transplantation.肾移植后的癌症
Transplant Rev (Orlando). 2008 Apr;22(2):141-9. doi: 10.1016/j.trre.2007.12.004.
5
Malignancy in kidney transplant recipients.肾移植受者中的恶性肿瘤
Drugs. 2008;68 Suppl 1:11-9. doi: 10.2165/00003495-200868001-00003.
6
Aristolochic acid nephropathy: a worldwide problem.马兜铃酸肾病:一个全球性问题。
Kidney Int. 2008 Jul;74(2):158-69. doi: 10.1038/ki.2008.129. Epub 2008 Apr 16.
7
Identifying high risk groups and quantifying absolute risk of cancer after kidney transplantation: a cohort study of 15,183 recipients.识别肾移植后癌症的高危人群并量化绝对风险:一项针对15183名受者的队列研究。
Am J Transplant. 2007 Sep;7(9):2140-51. doi: 10.1111/j.1600-6143.2007.01908.x. Epub 2007 Jul 19.
8
Malignancy after transplantation.移植后恶性肿瘤
Transplantation. 2005 Oct 15;80(2 Suppl):S254-64. doi: 10.1097/01.tp.0000186382.81130.ba.
9
Transitional cell carcinoma in renal transplant recipients.肾移植受者的移行细胞癌
Transplant Proc. 2004 Sep;36(7):2152-3. doi: 10.1016/j.transproceed.2004.08.017.
10
Cancer risk in patients on dialysis and after renal transplantation.透析患者及肾移植后患者的癌症风险。
Lancet. 2000 May 27;355(9218):1886-7. doi: 10.1016/s0140-6736(00)02298-4.

肾移植受者的新发恶性肿瘤:中国某单一中心的经验

De novo malignancies in renal transplant recipients: experience at a single center in China.

作者信息

Wu Bin, Wang Kai, Mo Chun-Ba, Shen Zhong-Yang

机构信息

Department of Transplant Surgery, First Central Hospital Clinc Institute, Tianjin Medical University China ; Key Laboratory of Organ Transplant of Tianjin China.

出版信息

Int J Clin Exp Med. 2015 Feb 15;8(2):2911-6. eCollection 2015.

PMID:25932254
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4402901/
Abstract

OBJECTIVE

Post-transplant malignancies are a major cause of morbidity and mortality after renal transplantation. This retrospective study investigated the incidence and outcome of de novo malignancies following kidney transplantation in a single China kidney transplantation center.

MATERIALS AND METHODS

Between 1989 and 2010, 1467 patients underwent kidney transplantation at transplantation center of Tianjin First Central Hospital of Tianjin Medical University. Data were analyzed for tumor incidence, clinical characteristics, and outcome. A review of the literature is also summarized.

RESULTS

After 1,467 renal transplantations, 5 men and 9 women (sex ratio 5:9) with a mean age of 54 years (21-64) were included for malignancies, an overall incidence of 0.954%. Urinary tract malignancies represented the most frequent malignancies (57%). The time of postoperative tumor occurring varied from 1 to 133 months with an average value of 42.78 months. Among them, 4 died and the mortality rate was 28.6%.

CONCLUSIONS

In short, with the increasing of transplant patients and the prolonging of survival time with kidney, the occurrence of malignancies will be increasing. This requires that we should set up perfect transplant follow-up system, and do regular follow-up and careful physical examination, do not overlook any early feature of tumor, at last achieve early diagnosis of tumor, and early treatment to improve the cure rate of postoperative malignancies of renal transplantation.

摘要

目的

移植后恶性肿瘤是肾移植后发病和死亡的主要原因。本回顾性研究调查了中国一家单一肾脏移植中心肾移植后新发恶性肿瘤的发生率和转归情况。

材料与方法

1989年至2010年期间,天津医科大学天津第一中心医院移植中心有1467例患者接受了肾脏移植。对肿瘤发生率、临床特征和转归数据进行了分析。还总结了文献综述。

结果

1467例肾移植后,纳入了5名男性和9名女性(性别比为5:9)发生恶性肿瘤,平均年龄54岁(21 - 64岁),总体发生率为0.954%。泌尿系统恶性肿瘤是最常见的恶性肿瘤(57%)。术后肿瘤发生时间为1至133个月,平均值为42.78个月。其中4例死亡,死亡率为28.6%。

结论

简而言之,随着移植患者数量的增加以及肾脏存活时间的延长,恶性肿瘤的发生将会增加。这就要求我们建立完善的移植随访体系,定期进行随访并仔细体检,不忽视肿瘤的任何早期特征,最终实现肿瘤的早期诊断和早期治疗,以提高肾移植术后恶性肿瘤的治愈率。